Immunovia completes analytical validation of its next-generation pancreatic cancer test ...Middle East

LUND, Sweden, Oct. 2, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has completed the analytical validation of its next-generation test designed to detect early-stage pancreatic cancer. The validation...

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia completes analytical validation of its next-generation pancreatic cancer test )

Also on site :

• Qatar PM: Iran strike inflicted ‘scar’ on relations
• Breast cancer survivors may have a lower risk of Alzheimer’s disease, experts say
• Palestinians in Gaza are calling for their own ceasefire